News and Announcements
MedAdvisor Acquisition and Fund Raising Presentation
- Published September 16, 2016 11:55AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
12th September 2016, ASX Announcement
MedAdvisor Limited (ASX: MDR, the Company) today provides its acquisition and fund raising presentation following the announcement on the 31 August 2016 that it has entered into an agreement to acquire 100% of Health Enterprises 2 Pty Ltd, trading as Healthnotes.
To view the full announcement, please click on the button below.
ABOUT MEDADVISOR
MedAdvisor International Pty Ltd (“MedAdvisor” or “the Company”) is an Australian medical technology business focused on designing and commercialising world class software platforms for medication management on mobile and internet devices.
MedAdvisor’s Platform connects to pharmacy dispensing systems, automatically retrieving medication records and driving an intelligent training, information and reminder system to ensure correct and reliable medication use.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
